Discontinuation report GLYXAMBI

Last updated on 2021-08-19 History
Report ID 139877
Drug Identification Number 02459760
Brand name GLYXAMBI
Common or Proper name GLYXAMBI 25/5MG 3X10S
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Market Status MARKETED
Active Ingredient(s) LINAGLIPTIN EMPAGLIFLOZIN
Strength(s) 5MG 25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 3X10 BLISTER PACK
ATC code A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-09-30
Actual discontinuation date
Remaining supply date 2021-09-30
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply Available until anticipated depletion now expected to be September 30, 2021
Company comments
Health Canada comments
Contact Address 5180 SOUTH SERVICE ROAD
BURLINGTON, ONTARIO
CANADA L7L 5H4
Company contact information 1800 263 2425

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-08-19 French Compare
v3 2021-08-19 English Compare
v2 2021-05-25 French Compare
v1 2021-05-25 English Compare